T.P. Sloan

A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.

David A. Evans, A. Mahgoub, T.P. Sloan et al. · Journal of Medical Genetics · 1980 · 540 citations · Full text

Genetics, Genetic Epidemiology, Human Polymorphism +20

Polymorphism of carbon oxidation of drugs and clinical implications.

T.P. Sloan, A. Mahgoub, Richard Lancaster et al. · BMJ · 1978 · 117 citations · Full text

Pharmacotherapy, Debrisoquine Metabolism, Oxidative Stress +18

Debrisoquin hydroxylation polymorphism among Ghanaians and Caucasians

N. M. Woolhouse, Benjamin Andoh, A. Mahgoub et al. · Clinical Pharmacology & Therapeutics · 1979 · 86 citations

Some observations on the oxidation phenotype status of Nigerian patients presenting with cancer

Jeffrey R. Idle, A. Mahgoub, T.P. Sloan et al. · Cancer Letters · 1981 · 79 citations

Cancer Risk, Oncogenic Agent, Medicine +8

A study of the debrisoquine hydroxylation polymorphism in a Nigerian population

Chibuike Mbanefo, Enitan A. Bababunmi, A. Mahgoub et al. · Xenobiotica · 1980 · 64 citations

Genetic Epidemiology, Human Polymorphism, Toxicological Mechanism +17